WELL Health Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

WELL Health Technologies wird ein Gewinn- und Umsatzwachstum von 25.6% bzw. 17.7% pro Jahr prognostiziert, während der Gewinn pro Aktie um 30.2% pro Jahr wachsen soll.

Wichtige Informationen

25.6%

Wachstumsrate der Gewinne

30.2%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	59.4%
Wachstumsrate der Einnahmen	17.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	28 Apr 2025

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Apr 23

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Apr 22

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Apr 01

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

Mar 29

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

Jan 19 Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Dec 31

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

Nov 29

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

Gewinn- und Umsatzwachstumsprognosen

TSX:WELL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2027	1,722	81	N/A	197	5
12/31/2026	1,531	54	89	154	13
12/31/2025	1,370	25	82	118	14
12/31/2024	920	33	-17	10	N/A
9/30/2024	958	73	112	127	N/A
6/30/2024	910	147	67	89	N/A
3/31/2024	838	30	49	68	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	-1	-1	N/A
10/31/2018	6	-2	N/A	-1	N/A
7/31/2018	4	-6	N/A	-1	N/A
4/30/2018	2	-6	N/A	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: WELLDas prognostizierte Gewinnwachstum (25.6% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: WELLDie Erträge des Unternehmens (25.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (16.5% pro Jahr).

Hohe Wachstumserträge: WELLEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: WELLDie Einnahmen des Unternehmens (17.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (4.9% pro Jahr).

Hohe Wachstumseinnahmen: WELLDie Einnahmen des Unternehmens (17.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von WELL in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2025/05/01 01:41
Aktienkurs zum Tagesende	2025/05/01 00:00
Gewinne	2024/12/31
Jährliche Einnahmen	2024/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

WELL Health Technologies Corp. wird von 15 Analysten beobachtet. 14 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus revenue estimates increase by 15%

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

Price target increased by 8.9% to CA$8.37

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Consensus revenue estimates increase by 15%

Full year 2024 earnings: EPS and revenues miss analyst expectations

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

WELL Health Technologies Corp., Annual General Meeting, Jun 19, 2025

WELL Health Technologies Corp. to Report Q4, 2024 Results on Apr 14, 2025

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Investor sentiment deteriorates as stock falls 21%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

Independent Director exercised options and sold CA$198k worth of stock

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Price target increased by 8.9% to CA$8.37

Investor sentiment improves as stock rises 23%

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock